Related Experiment Video
Updated: Aug 12, 2026
Assessing Specificity of Anticancer Drugs In Vitro
Published on: March 23, 2016
[Problem of screening of antineoplastic drugs in tissue and cell cultures]
Abstract:
Problems on the anticancer drugs' screening in vitro are reviewed on the basis of generalized data from literature. The probability to screen in vitro the active substances is not less than the chance to screen the drugs active against the human tumours in experiments on animals. The use of special test-systems permits screening specific substances including those inducing the tumour cell differentiation.
Insights
In vitro screening of anticancer drugs offers a high probability of identifying active substances, comparable to animal models. Specialized test systems enable the discovery of compounds that promote tumor cell differentiation.
Area of Science:
- Oncology
- Pharmacology
- Biotechnology
Context:
- Challenges in current anticancer drug screening methodologies.
- Limitations of traditional in vivo (animal) models for predicting human tumor response.
- Need for efficient and reliable in vitro screening platforms.
Purpose:
- To review the problems associated with in vitro anticancer drug screening.
- To evaluate the efficacy of in vitro methods compared to in vivo models.
- To highlight the potential of specialized test systems for identifying novel anticancer agents.
Summary:
- In vitro screening for anticancer drugs demonstrates a significant probability of success, equivalent to or exceeding that of animal models.
- Generalized literature data suggest in vitro methods are a viable alternative for identifying active anticancer substances.
- Advanced in vitro test systems can specifically screen for compounds that induce tumor cell differentiation, a promising therapeutic strategy.
Impact:
- Improved efficiency and reduced cost in anticancer drug discovery pipelines.
- Potential for faster identification of effective treatments for human cancers.
- Advancement of targeted therapies, including those that promote cancer cell differentiation.
